No abstract available
Keywords:
BCL2; PI3K/AKT; mantle cell lymphoma.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenine / analogs & derivatives
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Bridged Bicyclo Compounds, Heterocyclic / administration & dosage
-
Bridged Bicyclo Compounds, Heterocyclic / adverse effects
-
Disease-Free Survival
-
Female
-
Humans
-
Lymphoma, Mantle-Cell / drug therapy*
-
Lymphoma, Mantle-Cell / mortality*
-
Male
-
Phosphoinositide-3 Kinase Inhibitors
-
Piperidines
-
Pyrazoles / administration & dosage
-
Pyrazoles / adverse effects
-
Pyrimidines / administration & dosage
-
Pyrimidines / adverse effects
-
Sulfonamides / administration & dosage
-
Sulfonamides / adverse effects
-
Survival Rate
-
TOR Serine-Threonine Kinases / antagonists & inhibitors
Substances
-
Bridged Bicyclo Compounds, Heterocyclic
-
Phosphoinositide-3 Kinase Inhibitors
-
Piperidines
-
Pyrazoles
-
Pyrimidines
-
Sulfonamides
-
ibrutinib
-
MTOR protein, human
-
TOR Serine-Threonine Kinases
-
Adenine
-
venetoclax